Rare diseases
Investigational molecules
Locations
Back to Spain441 clinical trials in Murcia, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of Azenosertib (ZN-c3) for Women with Recurrent or Persistent Uterine Serous Carcinoma
SpainStudy on the Effects of VH4524184 for Adults Newly Diagnosed with HIV
SpainStudy on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
SpainStudy Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant
SpainSpainStudy on Metformin to Prevent High Blood Sugar in Advanced Breast Cancer Patients with Alpelisib and Endocrine Therapy
SpainStudy on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
SpainStudy Comparing Cook's Balloon and Dinoprostone for Inducing Labor in Pregnant Women with Fetal Growth Restriction at Term
SpainStudy on Methotrexate and Adalimumab for Non-Infectious Uveitis in Patients: Evaluating Effectiveness and Safety
SpainStudy on Povetacicept for Patients with Autoimmune Cytopenias (wAIHA, CAD, ITP)
SpainStudy on the Safety and Tolerability of BMS-986435 in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
SpainStudy on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hematologic malignancies, including studies of new therapeutic combinations for chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. Research aims to evaluate novel treatment approaches and improve patient outcomes.
Comprehensive studies evaluating treatments for various solid tumors, including innovative approaches for breast cancer, melanoma, and gastric cancer. Research focuses on targeted therapies and immunotherapy combinations.
Groundbreaking research in neurological disorders, particularly focusing on multiple sclerosis and acute cerebral ischemic stroke. Studies aim to evaluate new therapeutic agents and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
